The DOI matches its Crossref record; 61 of the 61 references it cites were found in a registry or an index.
COVID-19 gone bad: A new character in the spectrum of the hyperferritinemic syndrome?
Open accessAbstract
The severe form of COVID-19 share several clinical and laboratory features with four entities gathered under the term “hyperferritinemic syndromes” and including macrophage activation syndrome (MAS), adult-onset Still's disease (AOSD), catastrophic anti-phospholipid syndrome (CAPS) and septic shock. COVID-19 systemic inflammatory reaction and “hyperferritinemic syndromes” are all characterized by high serum ferritin and a life-threatening hyper-inflammation sustained by a cytokines storm which eventually leads to multi-organ failure. In this review, we analyze the possible epidemiological and molecular mechanisms responsible for hyper-inflammation in patients with severe COVID-19 and we underline the similarities between this condition and “hyperferritinemic syndromes” which would allow considering severe COVID-19 as a fifth member of this spectrum of inflammatory conditions.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
Huang, C., Wang, Y., Li, X., Ren, L., Zhao, J., Hu, Y., Zhang, L., Fan, G., Xu, J., Gu, X., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30183-5 · Cited by 48,884 · cited 2×
“The idea of a third later stage of COVID-19 as the dramatic result of an overwhelming cytokine storm [7] is strengthened by the observation of the increased level of different molecules including IL-1β, IL-1RA, IL7, IL-8, IL-9, IL-10, fibroblast growth factor (FGF), granulocyte-macrophage colony-stimulating factor (GM…”
Zhou, F., Yu, T., Du, R., Fan, G., Liu, Y., Liu, Z., Xiang, J., Wang, Y., Song, B., Gu, X., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30566-3 · Cited by 27,263 · cited 1×
“elevation of IL-6 in non-survival patients has been described [10].”
COVID-19: consider cytokine storm syndromes and immunosuppression
Mehta, P., McAuley, D. F., Brown, M., Sanchez, E., Tattersall, R. S., & Manson, J. J. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30628-0 · Cited by 9,664
Pathological findings of COVID-19 associated with acute respiratory distress syndrome
Xu, Z., Shi, L., Wang, Y., Zhang, J., Huang, L., Zhang, C., Liu, S., Zhao, P., Liu, H., Zhu, L., et al. (2020) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(20)30076-x · Cited by 8,545 · cited 1×
“Macroscopic features in autopsies include pleurisy, pericarditis, lung consolidation, pulmonary edema [34]; microscopic findings include diffuse alveolar damage with inflammatory infiltrates composed mainly by monocytes and macrophages, but minimal lymphocytes infiltration, and multinucleated giant cells alongside lar…”
Clinical and immunological features of severe and moderate coronavirus disease 2019
Chen, G., Wu, D., Guo, W., Cao, Y., Huang, D., Wang, H., Wang, T., Zhang, X., Chen, H., Yu, H., et al. (2020) · Journal of Clinical Investigation · doi:10.1172/jci137244 · Cited by 4,750
Yang, J., Zheng, Y., Gou, X., Pu, K., Chen, Z., Guo, Q., Ji, R., Wang, H., Wang, Y., & Zhou, Y. (2020) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2020.03.017 · Cited by 4,206
The ferritins: molecular properties, iron storage function and cellular regulation
Harrison, P. M., & Arosio, P. (1996) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/0005-2728(96)00022-9 · Cited by 2,667 · cited 1×
“Ferritin is a major intracellular iron storage protein and the ratio between its two subunits, H and L, may differ depending on tissue type and physiologic status of the cell [13] .”
BackgroundCovid-19 in Critically Ill Patients in the Seattle Region — Case Series
Bhatraju, P. K., Ghassemieh, B. J., Nichols, M., Kim, R., Jerome, K. R., Nalla, A. K., Greninger, A. L., Pipavath, S., Wurfel, M. M., Evans, L., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2004500 · Cited by 2,583
Angiotensin-converting enzyme 2 protects from severe acute lung failure
Imai, Y., Kuba, K., Rao, S., Huan, Y., Guo, F., Guan, B., Yang, P., Sarao, R., Wada, T., Leong-Poi, H., et al. (2005) · Nature · doi:10.1038/nature03712 · Cited by 2,453
Characteristics and outcomes of 21 critically ill patients with COVID-19 in Washington State
Arentz, M., Yim, E., Klaff, L., Lokhandwala, S., Riedo, F. X., Chong, M., & Lee, M. (2020) · JAMA · doi:10.1001/jama.2020.4326 · Cited by 2,259
Coagulopathy and Antiphospholipid Antibodies in Patients with Covid-19
Zhang, Y., Xiao, M., Zhang, S., Xia, P., Cao, W., Jiang, W., Chen, H., Ding, X., Zhao, H., Zhang, H., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmc2007575 · Cited by 2,179 · cited 1×
“It is of note that three Chinese COVID-19 patients admitted to ICU and presenting thrombotic events tested positive for anticardiolipin IgA antibodies as well as anti–β2 glycoprotein I IgA and IgG antibodies [32].”
Xu, X.-W., Wu, X.-X., Jiang, X.-G., Xu, K.-J., Ying, L.-J., Ma, C.-L., Li, S.-B., Wang, H.-Y., Zhang, S., Gao, H.-N., et al. (2020) · BMJ · doi:10.1136/bmj.m606 · Cited by 2,046
Cardiac Involvement in a Patient With Coronavirus Disease 2019 (COVID-19)
Inciardi, R. M., Lupi, L., Zaccone, G., Italia, L., Raffo, M., Tomasoni, D., Cani, D. S., Cerini, M., Farina, D., Gavazzi, E., et al. (2020) · JAMA Cardiology · doi:10.1001/jamacardio.2020.1096 · Cited by 1,858
Zhang, C., Wu, Z., Li, J.-W., Zhao, H., & Wang, G.-Q. (2020) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2020.105954 · Cited by 1,758
COVID-19 illness in native and immunosuppressed states: A clinical–therapeutic staging proposal
Siddiqi, H. K., & Mehra, M. R. (2020) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2020.03.012 · Cited by 1,701
McGonagle, D., Sharif, K., O'Regan, A., & Bridgewood, C. (2020) · Autoimmunity Reviews · doi:10.1016/j.autrev.2020.102537 · Cited by 1,654
Zhang, W., Zhao, Y., Zhang, F., Wang, Q., Li, T., Liu, Z., Wang, J., Qin, Y., Zhang, X., Yan, X., et al. (2020) · Clinical Immunology · doi:10.1016/j.clim.2020.108393 · Cited by 1,266
Conti, P. (2020) · Journal of Biological Regulators and Homeostatic Agents · doi:10.23812/conti-e · Cited by 1,227
Levi, M., & van der Poll, T. (2017) · Thrombosis Research · doi:10.1016/j.thromres.2016.11.007 · Cited by 846
Inflammatory Cytokines in the BAL of Patients With ARDS
Meduri, G. U., Kohler, G., Headley, S., Tolley, E., Stentz, F., & Postlethwaite, A. (1995) · Chest · doi:10.1378/chest.108.5.1303 · Cited by 695 · cited 1×
“In patients with ARDS, the lung epithelium and immune cell hyper-expression of IL-6 is associated with a poor disease outcome [55], as confirmed by a recent study on COVID-19 patients [56].”
Deng, Y., Liu, W., Liu, K., Fang, Y.-Y., Shang, J., Zhou, L., Wang, K., Leng, F., Wei, S., Chen, L., et al. (2020) · Chinese Medical Journal · doi:10.1097/cm9.0000000000000824 · Cited by 657
The Immunology of Macrophage Activation Syndrome
Crayne, C. B., Albeituni, S., Nichols, K. E., & Cron, R. Q. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00119 · Cited by 633
Gerfaud-Valentin, M., Jamilloux, Y., Iwaz, J., & Sève, P. (2014) · Autoimmunity Reviews · doi:10.1016/j.autrev.2014.01.058 · Cited by 518
Autopsy in suspected COVID-19 cases
Hanley, B., Lucas, S. B., Youd, E., Swift, B., & Osborn, M. (2020) · Journal of Clinical Pathology · doi:10.1136/jclinpath-2020-206522 · Cited by 478
Rosário, C., Zandman-Goddard, G., Meyron-Holtz, E. G., D’Cruz, D. P., & Shoenfeld, Y. (2013) · BMC Medicine · doi:10.1186/1741-7015-11-185 · Cited by 466
Serum ferritin is derived primarily from macrophages through a nonclassical secretory pathway
Cohen, L. A., Gutierrez, L., Weiss, A., Leichtmann-Bardoogo, Y., Zhang, D.-L., Crooks, D. R., Sougrat, R., Morgenstern, A., Galy, B., Hentze, M. W., et al. (2010) · Blood · doi:10.1182/blood-2009-11-253815 · Cited by 452 · cited 1×
“In vitro experiments demonstrated that ferritin might be actively secreted by hepatocytes [18] as well as by macrophages through a non-classical pathway [19] .”
BackgroundMacrophage activation syndrome in the era of biologic therapy
Grom, A. A., Horne, A., & De Benedetti, F. (2016) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2015.179 · Cited by 448
Monti, S., Balduzzi, S., Delvino, P., Bellis, E., Quadrelli, V. S., & Montecucco, C. (2020) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2020-217424 · Cited by 446
Is COVID-19 receiving ADE from other coronaviruses?
Tetro, J. A. (2020) · Microbes and Infection · doi:10.1016/j.micinf.2020.02.006 · Cited by 434
Zhang, Y., Cao, W., Xiao, M., Li, Y. J., Yang, Y., Zhao, J., Zhou, X., Jiang, W., Zhao, Y., Zhang, S., et al. (2020) · PubMed · doi:10.3760/cma.j.issn.0253-2727.2020.0006 · Cited by 397
Fung, S.-Y., Yuen, K.-S., Ye, Z.-W., Chan, C.-P., & Jin, D.-Y. (2020) · Emerging Microbes & Infections · doi:10.1080/22221751.2020.1736644 · Cited by 381
Interleukin-6 as a potential biomarker of COVID-19 progression
Ulhaq, Z. S., & Soraya, G. V. (2020) · Médecine et Maladies Infectieuses · doi:10.1016/j.medmal.2020.04.002 · Cited by 331
COVID-19 and diabetes: Can DPP4 inhibition play a role?
Iacobellis, G. (2020) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2020.108125 · Cited by 313
Ruddell, R. G., Hoang‐Le, D., Barwood, J. M., Rutherford, P. S., Piva, T. J., Watters, D. J., Santambrogio, P., Arosio, P., & Ramm, G. A. (2009) · Hepatology · doi:10.1002/hep.22716 · Cited by 298
Gabay, C., Fautrel, B., Rech, J., Spertini, F., Feist, E., Kötter, I., Hachulla, E., Morel, J., Schaeverbeke, T., Hamidou, M. A., et al. (2018) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2017-212608 · Cited by 291
Bracaglia, C., de Graaf, K., Pires Marafon, D., Guilhot, F., Ferlin, W., Prencipe, G., Caiello, I., Davì, S., Schulert, G., Ravelli, A., et al. (2017) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2015-209020 · Cited by 290
New functions for an iron storage protein: The role of ferritin in immunity and autoimmunity
Recalcati, S., Invernizzi, P., Arosio, P., & Cairo, G. (2008) · Journal of Autoimmunity · doi:10.1016/j.jaut.2007.11.003 · Cited by 259
Carter, S. J., Tattersall, R. S., & Ramanan, A. V. (2019) · Rheumatology · doi:10.1093/rheumatology/key006 · Cited by 259
Shoenfeld, Y. (2020) · Autoimmunity Reviews · doi:10.1016/j.autrev.2020.102538 · Cited by 227
Ferritin in autoimmune diseases
Zandman-Goddard, G., & Shoenfeld, Y. (2007) · Autoimmunity Reviews · doi:10.1016/j.autrev.2007.01.016 · Cited by 191
Sainz, B., Mossel, E. C., Peters, C. J., & Garry, R. F. (2004) · Virology · doi:10.1016/j.virol.2004.08.011 · Cited by 188
Nicastri, E., Petrosillo, N., Ascoli Bartoli, T., Lepore, L., Mondi, A., Palmieri, F., D’Offizi, G., Marchioni, L., Murachelli, S., Ippolito, G., et al. (2020) · Infectious Disease Reports · doi:10.4081/idr.2020.8543 · Cited by 177
First cases of COVID-19 in heart transplantation from China
Li, F., Cai, J., & Dong, N. (2020) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2020.03.006 · Cited by 174
IL-6 ameliorates acute lung injury in influenza virus infection
Yang, M.-L., Wang, C.-T., Yang, S.-J., Leu, C.-H., Chen, S.-H., Wu, C.-L., & Shiau, A.-L. (2017) · Scientific Reports · doi:10.1038/srep43829 · Cited by 159
Diagnostic morphology: biophysical indicators for iron-driven inflammatory diseases
Pretorius, E., & Kell, D. B. (2014) · Integrative Biology · doi:10.1039/c4ib00025k · Cited by 151
Regulated secretion of glycosylated human ferritin from hepatocytes
Ghosh, S., Hevi, S., & Chuck, S. L. (2003) · Blood · doi:10.1182/blood-2003-09-3050 · Cited by 140
Association between adult-onset Still's disease and interleukin-18 gene polymorphisms
Sugiura, T., Kawaguchi, Y., Harigai, M., Terajima-Ichida, H., Kitamura, Y., Furuya, T., Ichikawa, N., Kotake, S., Tanaka, M., Hara, M., et al. (2002) · Genes and Immunity · doi:10.1038/sj.gene.6363922 · Cited by 115
Ferritin as a Marker of Severity in COVID-19 Patients: A Fatal Correlation.
Dahan, S., Segal, G., Katz, I., Hellou, T., Tietel, M., Bryk, G., Amital, H., Shoenfeld, Y., & Dagan, A. (2020) · PubMed · Cited by 99
sCD163 in AOSD: a biomarker for macrophage activation related to hyperferritinemia
Colafrancesco, S., Priori, R., Alessandri, C., Astorri, E., Perricone, C., Blank, M., Agmon‐Levin, N., Shoenfeld, Y., & Valesini, G. (2014) · Immunologic Research · doi:10.1007/s12026-014-8563-7 · Cited by 83
Self-citationCOVID-19: Yet another coronavirus challenge in transplantation
Aslam, S., & Mehra, M. R. (2020) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2020.03.007 · Cited by 83
Ma, Y., Wu, M., Zhang, X., Xia, Q., Yang, J., Xu, S., & Pan, F. (2017) · Modern Rheumatology · doi:10.1080/14397595.2017.1416924 · Cited by 70
Umlauf, B. J., Haralambieva, I. H., Ovsyannikova, I. G., Kennedy, R. B., Pankratz, V. S., Jacobson, R. M., & Poland, G. A. (2012) · Viral Immunology · doi:10.1089/vim.2011.0051 · Cited by 56
Iron enhances generation of fibrin fibers in human blood: Implications for pathogenesis of stroke
Lipiński, B., Pretorius, E., Oberholzer, H. M., & van der Spuy, W. J. (2012) · Microscopy Research and Technique · doi:10.1002/jemt.22047 · Cited by 55
Parisi, F., Paglionico, A., Varriano, V., Ferraccioli, G., & Gremese, E. (2017) · Medicine · doi:10.1097/md.0000000000006656 · Cited by 54
Myocarditis in Adult-Onset Still Disease
Gerfaud‐Valentin, M., Sève, P., Iwaz, J., Gagnard, A., Broussolle, C., Durieu, I., Ninet, J., & Hot, A. (2014) · Medicine · doi:10.1097/md.0000000000000112 · Cited by 53
Spinelli, F. R., Ceccarelli, F., Franco, M. D., & Conti, F. (2020) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2020-217367 · Cited by 51
Self-citationPlatelet and endothelial activation in catastrophic and quiescent antiphospholipid syndrome
Bontadi, A., Falcinelli, E., Giannini, S., Marturano, A., Tonello, M., Hoxha, A., Pengo, V., Punzi, L., Momi, S., Gresele, P., et al. (2013) · Thrombosis and Haemostasis · doi:10.1160/th12-03-0212 · Cited by 45
Interplay of strain and race/ethnicity in the innate immune response to M. tuberculosis
Nahid, P., Jarlsberg, L. G., Kato‐Maeda, M., Segal, M. R., Osmond, D. H., Gagneux, S., Dobos, K. M., Gold, M. C., Hopewell, P. C., & Lewinsohn, D. M. (2018) · PLoS ONE · doi:10.1371/journal.pone.0195392 · Cited by 41
AOSD Consensus Group, Colafrancesco, S., MANARA, M., Bortoluzzi, A., Şerban, T., Bianchi, G., Cantarini, L., Ciccia, F., Dagna, L., Govoni, M., et al. (2019) · Arthritis Research & Therapy · doi:10.1186/s13075-019-2021-9 · Cited by 37
Self-citationWigginton, J. M. (1995) · Medical Hypotheses · doi:10.1016/0306-9877(95)90075-6 · Cited by 20
Environment impacts innate immune ontogeny
Garand, M., Cai, B., & Kollmann, T. R. (2016) · Innate Immunity · doi:10.1177/1753425916671018 · Cited by 12
Cited by
Management of post-acute covid-19 in primary care
Greenhalgh, T., Knight, M., A’Court, C., Buxton, M., & Husain, L. (2020) · BMJ · doi:10.1136/bmj.m3026 · Cited by 1,689
Short-term and Long-term Rates of Postacute Sequelae of SARS-CoV-2 Infection: A Systematic Review
Groff, D., Sun, A., Ssentongo, A. E., Ba, D. M., Parsons, N., Poudel, G. R., Lekoubou, A., Oh, J. S., Ericson, J. E., Ssentongo, P., et al. (2021) · JAMA Network Open · doi:10.1001/jamanetworkopen.2021.28568 · Cited by 998
Raveendran, A. V., Jayadevan, R., & Sashidharan, S. (2021) · Diabetes & Metabolic Syndrome: Clinical Research & Reviews · doi:10.1016/j.dsx.2021.04.007 · Cited by 921
“Reason for the persistence of symptoms can be the sequelae of organ damage, varying extent of injury (organ damage) and varying time required for the recovery of each organ system, persistence of chronic inflammation (convalescent phase) or immune response/auto antibody generation, rare persistence of virus in the bod…”
BackgroundCOVID-19 infection: an overview on cytokine storm and related interventions
Montazersaheb, S., Hosseiniyan Khatibi, S. M., Hejazi, M. S., Tarhriz, V., Farjami, A., Ghasemian Sorbeni, F., Farahzadi, R., & Ghasemnejad, T. (2022) · Virology Journal · doi:10.1186/s12985-022-01814-1 · Cited by 610
Ehrenfeld, M., Tincani, A., Andreoli, L., Cattalini, M., Greenbaum, A., Kanduc, D., Alijotas-Reig, J., Zinserling, V., Semenova, N., Amital, H., et al. (2020) · Autoimmunity Reviews · doi:10.1016/j.autrev.2020.102597 · Cited by 559
Metadata
- Authors
- Colafrancesco, S., Alessandri, C., Conti, F., & Priori, R.
- Venue
- Autoimmunity Reviews
- Publisher
- Elsevier BV
- Published
- 2020-07
- Volume
- 19
- Issue
- 7
- Pages
- 102573
- ISSN
- 1568-9972 (ISSN-L)
- OpenAlex
- W3022721402
- Cited by
- 268
- References
- 61
- FWCI
- 31.86
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.